Tissue Regenix Group (LSE:TRX) Price-to-Operating-Cash-Flow : 51.67 (As of May. 22, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Price-to-Operating-Cash-Flow?

As of today (2024-05-22), Tissue Regenix Group's share price is £0.62. Tissue Regenix Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.01. Hence, Tissue Regenix Group's Price-to-Operating-Cash-Flow Ratio for today is 51.67.

The historical rank and industry rank for Tissue Regenix Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

LSE:TRX' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 42.5 Med: 51.25 Max: 59.58
Current: 51.67

During the past 13 years, Tissue Regenix Group's highest Price-to-Operating-Cash-Flow Ratio was 59.58. The lowest was 42.50. And the median was 51.25.

LSE:TRX's Price-to-Operating-Cash-Flow is ranked worse than
75.17% of 290 companies
in the Biotechnology industry
Industry Median: 26.84 vs LSE:TRX: 51.67

Tissue Regenix Group's Cash Flow from Operations per share for the six months ended in Dec. 2023 was £0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.01.

During the past 13 years, Tissue Regenix Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 70.30% per year. The lowest was -50.40% per year. And the median was -7.80% per year.

Tissue Regenix Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Tissue Regenix Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Price-to-Operating-Cash-Flow Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

43.33

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	43.33

Competitive Comparison of Tissue Regenix Group's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Tissue Regenix Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tissue Regenix Group's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's Price-to-Operating-Cash-Flow falls into.

Tissue Regenix Group Price-to-Operating-Cash-Flow Calculation

Tissue Regenix Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.62	/	0.012
	=	51.67

Tissue Regenix Group's Share Price of today is £0.62.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tissue Regenix Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Tissue Regenix Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.